 |
 |
> Teva's Azilect Use Dramatically Increases In Second-Line Therapy For The > Treatment Of Parkinson's Disease > Main Category: Parkinson's Disease > Also Included In: Clinical Trials / Drug Trials > Article Date: 05 Mar 2009 - 1:00 PST article heavily diffused by: http://www.decisionresources.com/consulting_services.htm maryse ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn